22nd Century Group Future Growth
Future criteria checks 2/6
22nd Century Group is forecast to grow earnings and revenue by 34.5% and 21.3% per annum respectively while EPS is expected to grow by 61.3% per annum.
Key information
34.5%
Earnings growth rate
61.3%
EPS growth rate
Tobacco earnings growth | 18.9% |
Revenue growth rate | 21.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 28 Mar 2024 |
Recent future growth updates
Recent updates
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher
Apr 02Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook
Aug 20With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For
Jun 14Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?
Jan 1322nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado
Oct 0322nd Century Group to expand sales of VLN tobacco cigarettes
Sep 0722nd Century Group (NASDAQ:XXII) Has Debt But No Earnings; Should You Worry?
Sep 0222nd Century GAAP EPS of -$0.06 in-line, revenue of $14.5M beats by $3.21M
Aug 0922nd Century Group launches $35M securities offering
Jul 21Will 22nd Century Group (NASDAQ:XXII) Spend Its Cash Wisely?
May 1022nd Century Group: Record Revenues On VLN Cigarettes And Cannabis IP
May 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 35 | -33 | N/A | N/A | 1 |
12/31/2024 | 34 | -42 | N/A | N/A | 1 |
12/31/2023 | 22 | -65 | -61 | -55 | N/A |
9/30/2023 | 84 | -139 | -75 | -69 | N/A |
6/30/2023 | 84 | -78 | -75 | -69 | N/A |
3/31/2023 | 75 | -69 | -67 | -61 | N/A |
12/31/2022 | 28 | -37 | -56 | -52 | N/A |
9/30/2022 | 49 | -47 | -41 | -37 | N/A |
6/30/2022 | 39 | -44 | -32 | -30 | N/A |
3/31/2022 | 30 | -36 | -28 | -27 | N/A |
12/31/2021 | 31 | -33 | -24 | -23 | N/A |
9/30/2021 | 23 | -25 | -22 | -21 | N/A |
6/30/2021 | 25 | -20 | -17 | -16 | N/A |
3/31/2021 | 28 | -21 | -15 | -15 | N/A |
12/31/2020 | 28 | -20 | -16 | -16 | N/A |
9/30/2020 | 28 | -20 | -16 | -16 | N/A |
6/30/2020 | 27 | -26 | -18 | -17 | N/A |
3/31/2020 | 27 | -29 | -16 | -15 | N/A |
12/31/2019 | 26 | -27 | -16 | -15 | N/A |
9/30/2019 | 26 | -29 | -18 | -17 | N/A |
6/30/2019 | 26 | -13 | -20 | -18 | N/A |
3/31/2019 | 27 | -11 | -20 | -19 | N/A |
12/31/2018 | 26 | -8 | -19 | -18 | N/A |
9/30/2018 | 25 | -3 | -16 | -15 | N/A |
6/30/2018 | 24 | -12 | -15 | -13 | N/A |
3/31/2018 | 20 | -9 | -14 | -13 | N/A |
12/31/2017 | 17 | -13 | -14 | -12 | N/A |
9/30/2017 | 14 | -12 | N/A | -12 | N/A |
6/30/2017 | 13 | -11 | N/A | -11 | N/A |
3/31/2017 | 11 | -11 | N/A | -10 | N/A |
12/31/2016 | 12 | -12 | N/A | -10 | N/A |
9/30/2016 | 12 | -12 | N/A | -10 | N/A |
6/30/2016 | 11 | -12 | N/A | -10 | N/A |
3/31/2016 | 11 | -10 | N/A | -8 | N/A |
12/31/2015 | 9 | -11 | N/A | -7 | N/A |
9/30/2015 | 6 | -14 | N/A | -8 | N/A |
6/30/2015 | 3 | -14 | N/A | -8 | N/A |
3/31/2015 | 1 | -14 | N/A | -8 | N/A |
12/31/2014 | 1 | -16 | N/A | -7 | N/A |
9/30/2014 | 8 | -18 | N/A | 2 | N/A |
6/30/2014 | 8 | -30 | N/A | 3 | N/A |
3/31/2014 | 8 | -29 | N/A | 4 | N/A |
12/31/2013 | 7 | -26 | N/A | 4 | N/A |
9/30/2013 | 0 | -23 | N/A | -3 | N/A |
6/30/2013 | 0 | -8 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XXII is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: XXII is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: XXII is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: XXII's revenue (21.3% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: XXII's revenue (21.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XXII's Return on Equity is forecast to be high in 3 years time